Literature DB >> 32726420

Identifying the Radioresponsive Genome for Genomics-Guided Radiotherapy.

Catharine M L West1.   

Abstract

Year:  2021        PMID: 32726420      PMCID: PMC7936048          DOI: 10.1093/jnci/djaa098

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  8 in total

1.  Radiation therapy and adjuvant chemotherapy in a patient with a malignant glioneuronal tumor and underlying ataxia telangiectasia: a case report and review of the literature.

Authors:  Mariko D DeWire; Chris Beltran; Frederick A Boop; Kathleen J Helton; David W Ellison; Peter J McKinnon; Amar Gajjar; Atmaram S Pai Panandiker
Journal:  J Clin Oncol       Date:  2012-06-11       Impact factor: 44.544

2.  Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy.

Authors:  Kenneth L Pitter; Dana L Casey; Yue C Lu; Margaret Hannum; Zhigang Zhang; Xinmao Song; Isabella Pecorari; Biko McMillan; Jennifer Ma; Robert M Samstein; Isaac X Pei; Atif J Khan; Lior Z Braunstein; Luc G T Morris; Christopher A Barker; Andreas Rimner; Kaled M Alektiar; Paul B Romesser; Christopher H Crane; Joachim Yahalom; Michael J Zelefsky; Howard I Scher; Jonine L Bernstein; Diana L Mandelker; Britta Weigelt; Jorge S Reis-Filho; Nancy Y Lee; Simon N Powell; Timothy A Chan; Nadeem Riaz; Jeremy Setton
Journal:  J Natl Cancer Inst       Date:  2021-03-01       Impact factor: 13.506

3.  Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.

Authors:  Christian Nicolaj Andreassen; Barry S Rosenstein; Sarah L Kerns; Harry Ostrer; Dirk De Ruysscher; Jamie A Cesaretti; Gillian C Barnett; Alison M Dunning; Leila Dorling; Catharine M L West; Neil G Burnet; Rebecca Elliott; Charlotte Coles; Emma Hall; Laura Fachal; Ana Vega; Antonio Gómez-Caamaño; Christopher J Talbot; R Paul Symonds; Kim De Ruyck; Hubert Thierens; Piet Ost; Jenny Chang-Claude; Petra Seibold; Odilia Popanda; Marie Overgaard; David Dearnaley; Matthew R Sydes; David Azria; Christine Anne Koch; Matthew Parliament; Michael Blackshaw; Michael Sia; Maria J Fuentes-Raspall; Teresa Ramon Y Cajal; Agustin Barnadas; Danny Vesprini; Sara Gutiérrez-Enríquez; Meritxell Mollà; Orland Díez; John R Yarnold; Jens Overgaard; Søren M Bentzen; Jan Alsner
Journal:  Radiother Oncol       Date:  2016-07-18       Impact factor: 6.280

Review 4.  The Implications of Genetic Testing on Radiation Therapy Decisions: A Guide for Radiation Oncologists.

Authors:  Carmen Bergom; Catharine M West; Daniel S Higginson; Mohamed E Abazeed; Banu Arun; Soren M Bentzen; Jonine L Bernstein; Jaden D Evans; Naamit K Gerber; Sarah L Kerns; Judy Keen; Jennifer K Litton; Anne S Reiner; Nadeem Riaz; Barry S Rosenstein; Gabriel O Sawakuchi; Simona F Shaitelman; Simon N Powell; Wendy A Woodward
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-08-02       Impact factor: 7.038

5.  A single ataxia telangiectasia gene with a product similar to PI-3 kinase.

Authors:  K Savitsky; A Bar-Shira; S Gilad; G Rotman; Y Ziv; L Vanagaite; D A Tagle; S Smith; T Uziel; S Sfez; M Ashkenazi; I Pecker; M Frydman; R Harnik; S R Patanjali; A Simmons; G A Clines; A Sartiel; R A Gatti; L Chessa; O Sanal; M F Lavin; N G Jaspers; A M Taylor; C F Arlett; T Miki; S M Weissman; M Lovett; F S Collins; Y Shiloh
Journal:  Science       Date:  1995-06-23       Impact factor: 47.728

6.  Pan-cancer analysis of whole genomes.

Authors: 
Journal:  Nature       Date:  2020-02-05       Impact factor: 49.962

7.  Genomic analysis of exceptional responders to radiotherapy reveals somatic mutations in ATM.

Authors:  Jennifer Ma; Jeremy Setton; Luc Morris; Pedro Blecua Carrillo Albornoz; Christopher Barker; Benjamin H Lok; Eric Sherman; Nora Katabi; Kathryn Beal; Ian Ganly; Simon N Powell; Nancy Lee; Timothy A Chan; Nadeem Riaz
Journal:  Oncotarget       Date:  2017-02-07

8.  Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.

Authors:  Christopher C Parker; Nicholas D James; Christopher D Brawley; Noel W Clarke; Alex P Hoyle; Adnan Ali; Alastair W S Ritchie; Gerhardt Attard; Simon Chowdhury; William Cross; David P Dearnaley; Silke Gillessen; Clare Gilson; Robert J Jones; Ruth E Langley; Zafar I Malik; Malcolm D Mason; David Matheson; Robin Millman; J Martin Russell; George N Thalmann; Claire L Amos; Roberto Alonzi; Amit Bahl; Alison Birtle; Omar Din; Hassan Douis; Chinnamani Eswar; Joanna Gale; Melissa R Gannon; Sai Jonnada; Sara Khaksar; Jason F Lester; Joe M O'Sullivan; Omi A Parikh; Ian D Pedley; Delia M Pudney; Denise J Sheehan; Narayanan Nair Srihari; Anna T H Tran; Mahesh K B Parmar; Matthew R Sydes
Journal:  Lancet       Date:  2018-10-21       Impact factor: 79.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.